CS logo
small CS logo
Saitama Medical Center

Kawagoe, Saitama, Japan
University hospital in Kawagoe
1981番地 Kamoda, Kawagoe, Saitama 350-8550

About Saitama Medical Center


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Loxo Oncology, Inc.
4
Amgen
3
Pfizer
3
Galapagos NV
2
Janssen Pharmaceutical K.K.
2
Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan
2
AbbVie
1
Astex Pharmaceuticals, Inc.
1
AstraZeneca
1
Biogen
1
Boston Scientific Japan K.K.
1
Total Rows: 28

Clinical Trials at Saitama Medical Center


During the past decade, Saitama Medical Center conducted 24 clinical trials. In the 10-year time frame, 24 clinical trials started and 10 clinical trials were completed, i.e. on average, 41.7% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 4 clinical trials were completed. i.e. 40% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years22116600553355222200330011111122Started TrialsCompleted Trails2015201620172018201920202021202202468
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Therapeutic Hypothermia for Severe Traumatic Brain Injury in Japan
2002-12-01
2008-09-01
Completed
150
Tegafur-Uracil or Observation in Treating Patients With Stage II Colorectal Cancer That Has Been Completely Removed By Surgery
2006-10-01
2016-09-01
Completed
2,025
Tolvaptan Phase 3 Efficacy and Safety Study in Autosomal Dominant Polycystic Kidney Disease (ADPKD)
2007-01-01
2012-01-01
Completed
1,445
Long-Term, Open-Label Study Of CP-690,550 For Treatment Of Rheumatoid Arthritis In Japan
2008-04-01
2013-12-01
Completed
487
Identifying Prognostic Factors in Patients Receiving Tegafur-Uracil for Stage II Colon Cancer That Was Completely Removed By Surgery
2006-10-01
2016-09-01
Completed
1,111
Success of Tocilizumab in RA Patients With Remission Induction and Sustained Efficacy After Discontinuation
2009-10-01
2014-12-01
Completed
233
Efficacy and Safety of Adalimumab 80 mg Every Other Week With Methotrexate
2011-01-01
Unknown status
40
Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)
2010-10-27
2017-12-28
Completed
403

Rows per page:

1–38 of 38

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Saitama Medical Center" #1 sponsor was "Loxo Oncology, Inc." with 4 trials, followed by "Amgen" with 3 trials sponsored, "Pfizer" with 3 trials sponsored, "Galapagos NV" with 2 trials sponsored and "Janssen Pharmaceutical K.K." with 2 trials sponsored. Other sponsors include 19 different institutions and companies that sponsored additional 28 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Saitama Medical Center" #1 collaborator was "Eli Lilly and Company" with 4 trials as a collaborator, "Gilead Sciences" with 2 trials as a collaborator, "Saitama Medical University" with 2 trials as a collaborator, "Tokyo Medical and Dental University" with 2 trials as a collaborator and "Boehringer Ingelheim" with 1 trials as a collaborator. Other collaborators include 12 different institutions and companies that were collaborators in the rest 22 trials.
Created with Highcharts 11.1.0Top Leading SponsorsLoxo Oncology, Inc.: 4Loxo Oncology, Inc.: 4Amgen: 3Amgen: 3Pfizer: 3Pfizer: 3Galapagos NV: 2Galapagos NV: 2Janssen Pharmaceutical K.K.: 2Janssen Pharmaceutical K.K.: 2Translational ResearchCenter for MedicalInnovation, Kobe,Hyogo, Japan: 2Translational ResearchCenter for MedicalInnovation, Kobe,Hyogo, Japan: 2AbbVie: 1AbbVie: 1Astex Pharmaceuticals, Inc.: 1Astex Pharmaceuticals, Inc.: 1AstraZeneca: 1AstraZeneca: 1Biogen: 1Biogen: 1

Created with Highcharts 11.1.0Top CollaboratorsEli Lilly and Company: 4Eli Lilly and Company: 4Gilead Sciences: 2Gilead Sciences: 2Saitama Medical University: 2Saitama Medical University: 2Tokyo Medical andDental University: 2Tokyo Medical andDental University: 2Boehringer Ingelheim: 1Boehringer Ingelheim: 1Japan Agency forMedical Research andDevelopment: 1Japan Agency forMedical Research andDevelopment: 1Japan Blood ProductsOrganization: 1Japan Blood ProductsOrganization: 1Japan Clinical OncologyGroup: 1Japan Clinical OncologyGroup: 1Japan Clinical ResearchSupport Unit(J-CRSU): 1Japan Clinical ResearchSupport Unit(J-CRSU): 1Kurashiki Central Hospital: 1Kurashiki Central Hospital: 1

Clinical Trials Conditions at Saitama Medical Center


According to Clinical.Site data, the most researched conditions in "Saitama Medical Center" are "Rheumatoid Arthritis" (6 trials), "Chronic Lymphocytic Leukemia" (3 trials), "Crohn's Disease" (3 trials), "Small Lymphocytic Lymphoma" (3 trials) and "Colorectal Cancer" (2 trials). Many other conditions were trialed in "Saitama Medical Center" in a lesser frequency.

Clinical Trials Intervention Types at Saitama Medical Center


Most popular intervention types in "Saitama Medical Center" are "Drug" (29 trials), "Biological" (4 trials), "Device" (2 trials), "Other" (2 trials) and "Radiation" (2 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (6 trials), "Rituximab" (4 trials), "Carfilzomib" (3 trials), "Dexamethasone" (3 trials) and "Pirtobrutinib" (3 trials). Other intervention names were less common.

Clinical Trials Genders at Saitama Medical Center


The vast majority of trials in "Saitama Medical Center" are 36 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.

Clinical Trials Status at Saitama Medical Center


Currently, there are NaN active trials in "Saitama Medical Center". undefined are not yet recruiting, 10 are recruiting, 3 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 20 completed trials in Saitama Medical Center, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Saitama Medical Center, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 24 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 2 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 24Phase 3: 24Phase 4: 3Phase 4: 3Not Applicable: 2Not Applicable: 2Phase 2: 2Phase 2: 2

Created with Highcharts 11.1.0Trials StatusCompleted: 20Completed: 20Recruiting: 10Recruiting: 10Unknown status: 4Unknown status: 4Active, not recruiting: 3Active, not recruiting: 3Enrolling by invitation: 1Enrolling by invitation: 1